๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Inhibition of dopamine synthesis in striatal slices by the D1 agonist SKF 38393 is not mediated by D1 dopamine receptors

โœ Scribed by Richard J. Brooderson; Francis J. White; Dr. Mathew P. Galloway

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
335 KB
Volume
6
Category
Article
ISSN
0887-4476

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Antiparkinsonian effects of the novel D3
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors
โœ Michael P. Hill; Paula Ravenscroft; Steven G. McGuire; Jonathan M. Brotchie; Ala ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 95 KB

L-dopa remains the most common treatment for Parkinson's disease. However, there is considerable interest in D3/D2 receptor agonists such as the novel agent S32504, since they exert antiparkinsonian properties in the absence of dyskinesia. An important question concerns the roles of D2 vs. D3 recept